INTERPACE BIOSCIENCES, INC. Stockholders Equity

Quick Answer

INTERPACE BIOSCIENCES, INC. reported Stockholders Equity of $22.36 million for fiscal year 2025.

INTERPACE BIOSCIENCES, INC. Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $22.36M +1108.7%
2024 -$2.22M +95.6%
2024 -$50.54M +3.3%
2024 -$52.28M +4.5%
2024 -$54.77M +1.4%
2023 -$55.54M +2.1%
2023 -$56.72M -0.1%
2023 -$56.68M +1.2%
2023 -$57.39M +1.2%
2022 -$58.09M -36.9%
2021 -$42.42M -45.9%
2020 -$29.08M -33.4%
2020 -$21.80M -35.2%
2020 -$16.13M -48.0%
2020 -$10.90M -143.3%
2019 -$4.48M -174.3%
2019 $6.03M -54.8%
2019 $13.35M -27.4%
2019 $18.37M +18.9%
2018 $15.45M -56.3%
2018 $35.37M -8.2%
2018 $38.55M -3.1%
2018 $39.77M -0.3%
2017 $39.87M +0.0%
2016 $39.87M +205.8%
2015 $13.04M -35.2%
2014 $20.12M -38.0%
2013 $32.48M -8.8%
2012 $35.63M -40.1%
2011 $59.52M

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
September 30, 2025 -$298.0K +99.4% +75.4%
June 30, 2025 -$1.21M +97.7% -108.4%
March 31, 2025 -$582.0K +98.9% +73.7%
December 31, 2024 -$2.22M +96.0% +95.6%
September 30, 2024 -$50.54M +19.4% +3.3%
June 30, 2024 -$52.28M +16.0% +4.5%
March 31, 2024 -$54.77M +12.4% +1.4%
December 31, 2023 -$55.54M +11.9% +11.4%
  • INTERPACE BIOSCIENCES, INC. showed an increase of +1108.7% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2011–2025 period, INTERPACE BIOSCIENCES, INC.’s stockholders equity has declined by 62.4% (from $59.52 million to $22.36 million).
  • The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment